Boston Scientific
BSX
BSX
900 hedge funds and large institutions have $56.8B invested in Boston Scientific in 2022 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 355 increasing their positions, 287 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $54.6B → $56.8B (+$2.23B)
0.31% less ownership
Funds ownership: 90.34% → 90.03% (-0.31%)
14% less call options, than puts
Call options by funds: $312M | Put options by funds: $361M
Holders
900
Holding in Top 10
14
Calls
$312M
Puts
$361M
Top Buyers
| 1 | +$303M | |
| 2 | +$285M | |
| 3 | +$238M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$141M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$95.6M |
Top Sellers
| 1 | -$642M | |
| 2 | -$338M | |
| 3 | -$274M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$271M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$256M |